“My team and I love that we can just pick up the phone and discuss or debate a variant characterization or a therapy selection. N-of-One’s consultative approach to partnering sets them apart from other solutions.”
— Mark Kruzel, MD, MBA, Medical Science Liason, med fusion
N-of-One’s approach combines expert curation, the insights of oncology experts, and a proprietary technology and knowledgebase, MarkerMine™, to provide curated, high-quality, and actionable clinical interpretation of molecular tests.
N-of-One’s team of Ph.D. scientists and oncologists provide a synthesis of relevant scientific and clinical evidence, and link each patient’s tumor profile with potential therapeutic strategies, including clinical trials.